4506 — Sumitomo Pharma Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual cashflow statement for Sumitomo Pharma Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	36,829	40,600	-96,714	-314,929	23,635
Depreciation
Non-Cash Items	52,197	49,850	87,168	118,520	-17,691
Unusual Items
Other Non-Cash Items
Changes in Working Capital	23,902	-97,559	-20,915	-82,114	-28,178
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	135,601	31,239	10,802	-240,758	3,328
Capital Expenditures	-10,806	-13,494	-12,742	-15,730	-13,030
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	19,681	-4,784	65,161	48,766	112,784
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	8,875	-18,278	52,419	33,036	99,754
Financing Cash Flow Items	-17,335	-870	-197,436	659	566
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities	-57,215	-21,426	-146,817	77,851	-108,836
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	91,990	9,286	-59,506	-114,431	-5,931